blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2892556

EP2892556 - COMPOSITIONS AND METHODS RELATING TO THE TREATMENT OF DISEASES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  20.03.2020
Database last updated on 28.09.2024
FormerThe patent has been granted
Status updated on  12.04.2019
FormerGrant of patent is intended
Status updated on  05.12.2018
FormerExamination is in progress
Status updated on  19.12.2016
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK
published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Alfacyte Ltd
Biocity Scotland
Bo'ness Road
Newhouse
Lanarkshire
ML1 5UH / GB
[2017/10]
Former [2015/29]For all designated states
Alfacyte Ltd
7 Lawn Park
Milngavie
Glasgow G62 6HG / GB
Inventor(s)01 / STIMSON, William
7 Lawn Park
Milngavie
Glasgow G62 6HG / GB
 [2015/29]
Representative(s)Murgitroyd & Company
165-169 Scotland Street
Glasgow G5 8PL / GB
[N/P]
Former [2019/20]Murgitroyd & Company
Scotland House
165-169 Scotland Street
Glasgow G5 8PL / GB
Former [2015/29]Kiernan, Lisa
Murgitroyd & Company
Scotland House
165-169 Scotland Street
Glasgow G5 8PL / GB
Application number, filing date13763273.304.09.2013
[2019/20]
WO2013GB52316
Priority number, dateGB2012001587305.09.2012         Original published format: GB 201215873
[2015/29]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014037717
Date:13.03.2014
Language:EN
[2014/11]
Type: A1 Application with search report 
No.:EP2892556
Date:15.07.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 13.03.2014 takes the place of the publication of the European patent application.
[2015/29]
Type: B1 Patent specification 
No.:EP2892556
Date:15.05.2019
Language:EN
[2019/20]
Search report(s)International search report - published on:EP13.03.2014
(Supplementary) European search report - dispatched on:EP30.05.2016
ClassificationIPC:A61K39/35, A61K39/39, A61K38/21, A61P37/02, A61P37/08
[2015/29]
CPC:
A61K38/212 (EP,US); A61K39/35 (EP,US); A61K39/39 (EP,US);
A61P37/02 (EP); A61P37/08 (EP); A61K2039/542 (EP,US);
A61K2039/55522 (US); A61K2039/57 (EP,US); A61K2039/577 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/29]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN IM ZUSAMMENHANG MIT DER BEHANDLUNG VON KRANKHEITEN[2015/29]
English:COMPOSITIONS AND METHODS RELATING TO THE TREATMENT OF DISEASES[2015/29]
French:COMPOSITIONS ET PROCÉDÉS DE TRAITEMENT DE MALADIES[2015/29]
Entry into regional phase04.03.2015National basic fee paid 
04.03.2015Designation fee(s) paid 
04.03.2015Examination fee paid 
Examination procedure04.03.2015Examination requested  [2015/29]
01.10.2015Amendment by applicant (claims and/or description)
30.05.2016Despatch of a communication from the examining division to which search results under Rule 164(2) EPC are annexed (Time limit: M04) [2016/26]
30.05.2016Despatch of a communication from the examining division (Time limit: M04)
07.09.2016Reply to a communication from the examining division
08.12.2016Despatch of a communication from the examining division (Time limit: M04)
20.01.2017Reply to a communication from the examining division
02.10.2017Despatch of a communication from the examining division (Time limit: M06)
12.02.2018Reply to a communication from the examining division
29.10.2018Cancellation of oral proceeding that was planned for 08.11.2018
08.11.2018Date of oral proceedings (cancelled)
06.12.2018Communication of intention to grant the patent
02.04.2019Fee for grant paid
02.04.2019Fee for publishing/printing paid
02.04.2019Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  30.05.2016
Opposition(s)18.02.2020No opposition filed within time limit [2020/17]
Fees paidRenewal fee
30.09.2015Renewal fee patent year 03
26.09.2016Renewal fee patent year 04
29.09.2017Renewal fee patent year 05
28.09.2018Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU04.09.2013
AL15.05.2019
AT15.05.2019
CY15.05.2019
CZ15.05.2019
EE15.05.2019
HR15.05.2019
LT15.05.2019
LV15.05.2019
MC15.05.2019
MK15.05.2019
MT15.05.2019
RO15.05.2019
RS15.05.2019
SI15.05.2019
SK15.05.2019
SM15.05.2019
TR15.05.2019
BG15.08.2019
GR16.08.2019
LU04.09.2019
IS15.09.2019
PT15.09.2019
[2022/31]
Former [2021/34]HU04.09.2013
AL15.05.2019
AT15.05.2019
CY15.05.2019
CZ15.05.2019
EE15.05.2019
HR15.05.2019
LT15.05.2019
LV15.05.2019
MC15.05.2019
MT15.05.2019
RO15.05.2019
RS15.05.2019
SI15.05.2019
SK15.05.2019
SM15.05.2019
TR15.05.2019
BG15.08.2019
GR16.08.2019
LU04.09.2019
IS15.09.2019
PT15.09.2019
Former [2021/32]HU04.09.2013
AL15.05.2019
AT15.05.2019
CY15.05.2019
CZ15.05.2019
EE15.05.2019
HR15.05.2019
LT15.05.2019
LV15.05.2019
MC15.05.2019
RO15.05.2019
RS15.05.2019
SI15.05.2019
SK15.05.2019
SM15.05.2019
TR15.05.2019
BG15.08.2019
GR16.08.2019
LU04.09.2019
IS15.09.2019
PT15.09.2019
Former [2021/31]AL15.05.2019
AT15.05.2019
CY15.05.2019
CZ15.05.2019
EE15.05.2019
HR15.05.2019
LT15.05.2019
LV15.05.2019
MC15.05.2019
RO15.05.2019
RS15.05.2019
SI15.05.2019
SK15.05.2019
SM15.05.2019
TR15.05.2019
BG15.08.2019
GR16.08.2019
LU04.09.2019
IS15.09.2019
PT15.09.2019
Former [2021/26]AL15.05.2019
AT15.05.2019
CY15.05.2019
CZ15.05.2019
EE15.05.2019
HR15.05.2019
LT15.05.2019
LV15.05.2019
MC15.05.2019
RO15.05.2019
RS15.05.2019
SI15.05.2019
SK15.05.2019
SM15.05.2019
TR15.05.2019
BG15.08.2019
GR16.08.2019
LU04.09.2019
PT15.09.2019
Former [2020/35]AL15.05.2019
AT15.05.2019
CZ15.05.2019
EE15.05.2019
HR15.05.2019
LT15.05.2019
LV15.05.2019
MC15.05.2019
RO15.05.2019
RS15.05.2019
SI15.05.2019
SK15.05.2019
SM15.05.2019
TR15.05.2019
BG15.08.2019
GR16.08.2019
LU04.09.2019
PT15.09.2019
Former [2020/25]AL15.05.2019
AT15.05.2019
CZ15.05.2019
EE15.05.2019
HR15.05.2019
LT15.05.2019
LV15.05.2019
MC15.05.2019
RO15.05.2019
RS15.05.2019
SI15.05.2019
SK15.05.2019
SM15.05.2019
TR15.05.2019
BG15.08.2019
GR16.08.2019
PT15.09.2019
Former [2020/17]AL15.05.2019
AT15.05.2019
CZ15.05.2019
EE15.05.2019
HR15.05.2019
LT15.05.2019
LV15.05.2019
RO15.05.2019
RS15.05.2019
SK15.05.2019
SM15.05.2019
TR15.05.2019
BG15.08.2019
GR16.08.2019
PT15.09.2019
Former [2020/14]AL15.05.2019
AT15.05.2019
CZ15.05.2019
EE15.05.2019
HR15.05.2019
LT15.05.2019
LV15.05.2019
RO15.05.2019
RS15.05.2019
SK15.05.2019
SM15.05.2019
BG15.08.2019
GR16.08.2019
PT15.09.2019
Former [2020/11]AL15.05.2019
AT15.05.2019
CZ15.05.2019
EE15.05.2019
HR15.05.2019
LT15.05.2019
LV15.05.2019
RO15.05.2019
RS15.05.2019
SK15.05.2019
BG15.08.2019
GR16.08.2019
PT15.09.2019
Former [2020/10]AL15.05.2019
AT15.05.2019
CZ15.05.2019
HR15.05.2019
LT15.05.2019
LV15.05.2019
RO15.05.2019
RS15.05.2019
BG15.08.2019
GR16.08.2019
PT15.09.2019
Former [2020/09]AL15.05.2019
CZ15.05.2019
HR15.05.2019
LT15.05.2019
LV15.05.2019
RS15.05.2019
BG15.08.2019
GR16.08.2019
PT15.09.2019
Former [2019/51]AL15.05.2019
HR15.05.2019
LT15.05.2019
LV15.05.2019
RS15.05.2019
BG15.08.2019
GR16.08.2019
PT15.09.2019
Former [2019/50]AL15.05.2019
HR15.05.2019
LT15.05.2019
LV15.05.2019
RS15.05.2019
GR16.08.2019
PT15.09.2019
Former [2019/48]LT15.05.2019
PT15.09.2019
Former [2019/47]LT15.05.2019
Cited inInternational search[X]WO9524212  (IMPERIAL COLLEGE [GB], et al) [X] 1,12,16,26,30,40 * page 3, line 18 - line 21 * * page 3, line 11 - page 4, line 13; figure 1; claims 1-3, 7 *;
 [XI]US6350589  (MORRIS JOSEPH P [US], et al) [X] 1-3,11,12,16-18,25,26,30-32,39,40 * paragraph [0055] - paragraph [0057] * [I] 4-6,15,19-21,29,33-35,43;
 [A]WO2005123112  (TOVEY MICHAEL [FR], et al) [A] 1-6,11,12,15-21,25,26,29-35,39,40,43* paragraphs [0001] , [0008] , [0011] - [0021] - [0029] - [0036] - [0038] , [0041] - [0046]; examples 1-3; claims 1-16 *;
 [XI]  - SOUILLET G ET AL, "Alpha-interferon treatment of patient with hyper IgE syndrome.", LANCET, (19890617), vol. 333, no. 8651, ISSN 0140-6736, page 1384, XP002715899 [X] 1,2,5,12,16,17,20,26,30,31,34,40 * the whole document * [I] 6,11,15,21,25,29,35,39,43

DOI:   http://dx.doi.org/10.1016/S0140-6736(89)92823-7
 [XI]  - TILG HERBERT, "New insights into the mechanisms of interferon alfa: An immunoregulatory and anti-inflammatory cytokine", GASTROENTEROLOGY, (1997), vol. 112, no. 3, ISSN 0016-5085, pages 1017 - 1021, XP002715900 [X] 1-5,12,16-20,26,30-34,40 * the whole document, especially page 1017-page 1018, bridging paragraph * [I] 6,11,15,21,25,29,35,39,43

DOI:   http://dx.doi.org/10.1053/gast.1997.v112.pm9041265
ExaminationUS6436391
 WO02095067
 WO2006111745
    - IMD Berlin-Potsdam, "T-Helferzellstatus TH1/TH2/TH17/Treg-Profil", no. Diagnostikinformation 238, URL: http://www.imd-berlin.de/fileadmin/user_upload/Diag_Info/238_TH1217_Profil.pdf, (20160425), XP002756974
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.